Your browser doesn't support javascript.
loading
HER2 testing of gynecologic carcinosarcomas: tumor stratification for potential targeted therapy.
Rottmann, Douglas; Snir, Olivia L; Wu, Xinyu; Wong, Serena; Hui, Pei; Santin, Alessandro D; Buza, Natalia.
Afiliação
  • Rottmann D; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Snir OL; Department of Pathology, Oregon Health & Science University, Portland, OR, USA.
  • Wu X; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Wong S; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Hui P; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Santin AD; Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale School of Medicine, New Haven, CT, USA.
  • Buza N; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. natalia.buza@yale.edu.
Mod Pathol ; 33(1): 118-127, 2020 01.
Article em En | MEDLINE | ID: mdl-31477811
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Biomarcadores Tumorais / Receptor ErbB-2 / Neoplasias das Tubas Uterinas / Terapia de Alvo Molecular Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Uterinas / Carcinossarcoma / Biomarcadores Tumorais / Receptor ErbB-2 / Neoplasias das Tubas Uterinas / Terapia de Alvo Molecular Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos